CONTRASTIVE EXAMINATION OF THE CLINICAL TRAJECTORY OF COVID-19 IN THE PRESENCE OF CARDIOVASCULAR DISEASES

Анотація

In recent decades, public health has faced a series of significant challenges, particularly concerning cardiovascular diseases (CVD). World Health Organization data over the past three decades present alarming statistics: the prevalence of cardiovascular diseases (CVD) has more than doubled, reaching a level of 523 million cases compared to 271 million cases 30 years ago, which is a truly staggering indicator. Additionally, the number of deaths from CVD is impressive, totaling 18.6 million (17.1-19.7 million), indicating an urgent need for a deep understanding and overcoming of this issue [1, 2, 3]. In the context of contemporary challenges and threats related to public health, special attention is given to the impact of COVID-19 on the cardiovascular system. As emphasized in numerous scientific studies, coronavirus infection poses a serious threat to patients with pre-existing chronic conditions, including cardiovascular system involvement [4, 5, 6]. It is worth noting that the combination of COVID-19 and cardiovascular pathology presents the medical community with a series of complex challenges, including difficulties in diagnosis, treatment strategies, and the choice of patient management tactics in acute conditions [7, 8]. However, despite the relevance of the issue, there is a significant lack of clinical data regarding the interaction between CVD and COVID-19. This underscores the need for further research and improvement of approaches to the diagnosis and treatment of patients with a combination of these conditions. Therefore, in this article, we aim to analyze the existing issues, identify key challenges, and propose possible avenues for optimizing clinical practice in this area by examining the characteristics of the clinical course of COVID-19 in conjunction with cardiovascular pathology.